Translationale Biomedizin

  • ISSN: 2172-0479
  • H-Index der Zeitschrift: 16
  • Zitierbewertung der Zeitschrift: 5.91
  • Journal-Impact-Faktor: 3.66
Indiziert in
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • JournalTOCs
  • Forschungsbibel
  • Der Global Impact Factor (GIF)
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • Scimago
  • Elektronische Zeitschriftenbibliothek
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • OCLC – WorldCat
  • Proquest-Vorladungen
  • Publons
  • MIAR
  • Kommission für Universitätsstipendien
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
  • ResearchGate
Teile diese Seite

Abstrakt

Precision Medicine and Translation of Human-Induced Pluripotent Stem Cells: Review

Kenza Tani

The future of biomedical research has undergone a significant change as a result of the possibility of altering the flexibility of terminally differentiated cells toward pluripotency. Human-induced pluripotent stem cells (iPSCs) offer a fresh source of therapeutic cells free of the moral quandaries or immunological restrictions associated with human embryonic stem cells. iPSCs also provide significant benefits over traditional approaches of studying human diseases. Three key uses of iPSC technology have emerged since its inception: disease modelling, regenerative medicine, and drug development. Here, we thoroughly cover the most recent developments in iPSC technology in connection to fundamental, clinical, and public health.

Keywords

Pluripotent; Stem Cells; Translation